Skip to Content

Ammonul Medicis - Treatment for Urea Cycle Disorder

Ammonul is a combination of 10% sodium phenylacetate and 10% sodium benzoate indicated as an adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.

Posted: February 2005

Ammonul (sodium benzoate and sodium phenylacetate) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.